Bryson R. Koehler - 12 Feb 2024 Form 4 Insider Report for EQUIFAX INC (EFX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Feb 2024, 16:50:00 UTC
Prior SEC filing
13 Feb 2024
Next SEC filing
06 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Lisa Stockard as Attorney-in-Fact

Key filing fact

Bryson R. Koehler filed Form 4 for EQUIFAX INC (EFX) on 14 Feb 2024.

Key facts

  • This page summarizes Bryson R. Koehler's Form 4 filing for EQUIFAX INC (EFX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Feb 2024, 16:50.

Change

  • Previous filing in this sequence was filed on 13 Feb 2024.
  • Current net transaction value: -$654,797.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EFX transaction

Common Stock

Award

Transaction value
$0
Shares
+3,943
Change %
+19%
Price
$0.000000
Shares after
24,596
Date
12 Feb 2024
Ownership
Direct
Footnotes
F1
EFX transaction

Common Stock

Tax liability

Transaction value
$654,797
Shares
-2,560
Change %
-10%
Price
$255.78
Shares after
22,036
Date
12 Feb 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .